Laura Dormer: Real-World Safety of DOACs vs LMWH in Cancer-Associated VTE Acroos Europe
Laura Dormer, Co-Founder and Editorial Director at Becaris Publishing, shared on LinkedIn about a recent article by Ellen Brodin et al, published in Journal of Comparative Effectiveness Research, adding:
”Comparative safety of direct oral anticoagulants and low-molecular-weight heparin in patients with venous thromboembolism and cancer in Europe
Using observational healthcare datasets from five European countries, in this real-world study the authors examined bleeding outcomes associated with apixaban, rivaroxaban and low-molecular-weight heparin in routine clinical practice.
The study adds important real-world evidence to support treatment decision-making in oncology and thrombosis care.”
Title: Comparative safety of direct oral anticoagulants and low-molecular-weight heparin in patients with venous thromboembolism and cancer in Europe
Authors: Ellen Brodin, Annie Young, Florian Langer, Raza Alikhan, Lauri Timo, Dimitra Lambrelli, Beth Nordstrom, Alison Booth, Sophie Graham, Ruth Mokgokong, Aaron Jenkins, Jose Chaves, Feng Dai, Rupesh Subash, Moritz Lehne, Marco Ghiani, Antje Mevius, Daniela Fliegner, Anders Gottsäter

Stay updated on all scientific advances with Hemostasis Today.
-
Aug 28, 2026, 13:55Swatee C: A Guide to Common Uterine Disorders
-
Aug 28, 2026, 12:14Gathoni Kungu: Run to End Postpartum Hemorrhage and Save Lives
-
Aug 28, 2026, 12:09Joe Daniels: Heavy Periods Deserve Attention
-
Aug 28, 2026, 12:06Matthew Siedhoff: Understanding the Cause Behind Gynecological Symptoms
-
Aug 28, 2026, 12:03Archil Jaliashvili: Biological Hemoglobin Oxygen Carriers as a Bridge in Emergencies
-
Aug 28, 2026, 11:58Abdul Mannan: Can Amyloid-β Be Transmitted via Blood Components?
-
Aug 28, 2026, 11:56Bassem M. Mohammed: New Cryo-EM Study Reveals How Factor XIa Activates Factor IX
-
Aug 28, 2026, 11:38Rebecca Embleton: Understanding Bowel Dysfunction After Pelvic Radiotherapy
-
Aug 28, 2026, 11:33Fabrício Doin Paz de Oliveira: Hemorrhoidal Disease – Challenges and Treatment Options